Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation
Open accessThe DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Abstract
Human BCL-2-associated death promoter (hBAD) is an apoptosis-regulatory protein mediating survival signals to carcinoma cells upon phosphorylation of Ser99, among other residues. Herein, we screened multiple small-molecule databases queried in a Laplacian-modified naive Bayesian-based cheminformatics platform and identified a Petasis reaction product as a site-specific inhibitor for hBAD phosphorylation. Based on apoptotic efficacy against mammary carcinoma cells, N -cyclopentyl-3-((4-(2,3-dichlorophenyl) piperazin-1-yl) (2-hydroxyphenyl) methyl) benzamide (NPB) was identified as a potential lead compound. In vitro biochemical analyses demonstrated that NPB inhibited the phosphorylation of hBAD specifically on Ser99. NPB was observed to exert this effect independently of AKT and other kinase activities despite the demonstration of AKT-mediated BAD-Ser99 phosphorylation. Using a structure-based bioinformatics platform, we observed that NPB exhibited predicted interactions with hBAD in silico and verified the same by direct binding kinetics. NPB reduced phosphorylation of BAD-Ser99 and enhanced caspase 3/7 activity with associated loss of cell viability in various human cancer cell lines derived from mammary, endometrial, ovarian, hepatocellular, colon, prostatic, and pancreatic carcinoma. Furthermore, by use of a xenograft model, it was observed that NPB, as a single agent, markedly diminished BAD phosphorylation in tumor tissue and significantly inhibited tumor growth. Simila…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A small molecule (NPB) that inhibits BAD phosphorylation at S99, independent of kinase activity, and promotes apoptosis of cancer cells has been recently described [15].”
From Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer (2024) · cites this paper as [15]
In the citing paper
“Hence, as a core effector of both pathways, inhibition of the actions of phosphorylated BAD in cancer cells (herein with Ser99 mutated BAD or NPB) decreases cancer cell survival by promoting intrinsic apoptosis [15]; and more so in the presence of cytotoxic agents.”
From Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer (2024) · cites this paper as [15]
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · cited 3×
“The hBAD protein target was normalized by comparing the predicted targets in the dataset used in this study with target predictions of a background dataset comprising 3,000 compounds in total from PubChem, GDB13, and ChEMBL; a probability of 0.05 or higher was considered “as predicted” in this case.”
MethodInfluentialCellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
Programmed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031 · cited 1×
“BCL-xL is critical for determining platelet lifespan (57).”
BackgroundSchneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910 · cited 1×
“7 million compounds for predicted interaction with BAD using a unique in silico mapping of chemical space in the drug-discovery area (13).”
MethodMechanisms of Action of Bcl-2 Family Proteins
Shamas-Din, A., Kale, J., Leber, B., & Andrews, D. W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008714 · Cited by 705
Research works printed but not linked: 2
- 10.1021/ci049714 · DOI
- 10.1110/ps.9.12.2528 · doi:10.1110/ps.9.12.2528 · Paper page
Cited by
Reactivity and Synthetic Applications of Multicomponent Petasis Reactions
Wu, P., Givskov, M., & Nielsen, T. E. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00214 · Cited by 315
Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation
Hill, S. M., Wrobel, L., & Rubinsztein, D. C. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0254-9 · Cited by 216
Lee, J. H., Mohan, C. D., Deivasigamani, A., Jung, Y. Y., Rangappa, S., Basappa, B., Chinnathambi, A., Alahmadi, T. A., Alharbi, S. A., Garg, M., et al. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.07.004 · Cited by 144
Self-citationEscaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds
Jadimurthy, R., Mayegowda, S. B., Nayak, S. C., Mohan, C. D., & Rangappa, K. S. (2022) · Biotechnology Reports · doi:10.1016/j.btre.2022.e00728 · Cited by 116
Self-citationBrusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
Lee, J. H., Rangappa, S., Mohan, C. D., Basappa, B., Sethi, G., Lin, Z., Rangappa, K. S., & Ahn, K. S. (2019) · Biomolecules · doi:10.3390/biom9100550 · Cited by 81
Self-citation
Metadata
- Authors
- Pandey, V., Wang, B., Mohan, C. D., Raquib, A. R., Rangappa, S., Srinivasa, V., Fuchs, J. E., Girish, K. S., Zhu, T., Bender, A., Ma, L., Yin, Z., Basappa, Rangappa, K. S., & Lobie, P. E.
- Affiliations
- Tsinghua–Berkeley Shenzhen Institute (CN)
- Jinan University (CN)
- University of Mysore (IN)
- National University of Singapore (SG)
- Adichunchanagiri Institute for Molecular Medicine, BG Nagara, 571448 Karnataka, India;
- Bangalore University (IN)
- University of Cambridge (GB)
- Tumkur University (IN)
- University of Science and Technology of China (CN)
- Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, 560001 Bangalore, India;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-10-11
- Volume
- 115
- Issue
- 44
- Pages
- E10505-E10514
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6217419
- OpenAlex
- W2896536135
- Cited by
- 59
- References
- 75
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 1
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MyPrints@UOM (Mysore University Library) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bad phosphorylation, small molecule inhibitors, NPB, caspase-3/7 activation, apoptosis, cancer cell lines, xenograft tumor growth, structure-based drug design, anticancer agents
- MeSH terms
- Antineoplastic Agents, Benzamides, Cell Survival, Humans, Phosphorylation, Piperazines, Serine, Databases, Factual, Drug Delivery Systems, Apoptosis, Surface Plasmon Resonance, RNA Interference, Cell Proliferation, bcl-Associated Death Protein, Small Molecule Libraries, Drug Discovery, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation. https://app.cochat.ai/papers/10.1073/pnas.1804897115
- The paper
- Pandey, V., Wang, B., Mohan, C. D., Raquib, A. R., Rangappa, S., Srinivasa, V., Fuchs, J. E., Girish, K. S., Zhu, T., Bender, A., Ma, L., Yin, Z., Basappa, Rangappa, K. S., & Lobie, P. E. (2018). Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1804897115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.